volume matched to test product; provided by site
Sponsors
University Of Minnesota
Conditions
COVID-19
Phase 3
A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized Patients with Respiratory Infections: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE) - Immune Modulation Strategy Trial
CompletedCTIS2023-504487-41-00
Start: 2023-11-28End: 2025-08-11Target: 345Updated: 2025-05-09
An International Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Anti-Coronavirus Hyperimmune Intravenous Immunoglobulin for the Treatment of Adult Outpatients in Early Stages of COVID-19
RecruitingCTIS2023-508105-24-00
Start: 2021-11-11Target: 160Updated: 2024-12-17